血液病

改良R显带技术在恶性血液病染色体核型鉴定中的应用

Identifying caryotype of malignant hemopathy using modified reverse-banding technique

AL各项免疫指标明显低于其它恶性血液病；

The immune indexes of the acute leukemia were obviously lower than those of any other malignant hemopathy .

他患有一种罕见的血液病。

He suffers from a rare blood disease .

C反应蛋白在恶性血液病感染中的临床研究

CRP in Diagnosis of Infection among Patients with Malignant Hematological Disease : Clinical Study

恶性血液病血清叶酸、维生素B（12）的测定及其临床意义

Clinical Significance of Serum Folic Acid and Vitamin B_ ( 12 ) in Hematologic Malignancies

两性霉素B治疗恶性血液病侵袭性真菌感染患者的护理

Nursing Care of Amphotericin B in the Treatment of Invasive Fungal Infections to Patients with Malignant Hematological Diseases

1目的探讨降钙素（CT）基因高度甲基化与恶性血液病预后的关系。

Objective To study the relationship between calcitonin ( CT ) gene hypermethylation and the prognosis of malignant hematological disorders .

55例血液病患者骨髓细胞中EB病毒DNA检测

Detection of EB virus in marrow cell of fifty-five patients with pernicious hematopathy

CyclinE在恶性血液病中的表达及其意义恶性嗜铬细胞瘤

The Expression of Cyclin E in Human Malignant Hematopoietic Tumors and Its Significance

PCR检测降钙素基因甲基化及其在某些恶性血液病中的意义

Detection of the hypermethylation of calcitonin gene by polymerase chain reaction and its implication in some hematological malignancies

HLA单倍相合造血干细胞移植治疗恶性血液病的临床研究

Clinical study on haploid HLA-haploidentical hematopoietic stem cell transplantation for treatment of malignant hematological disease

血液病患者HCV感染状况的初步研究

A Preliminary Study of Infective Status of Hepatitis C Virus in Patients with Hematologic Diseases

66例血液病患者血小板输注效果与HLA关联的研究

The relationship between the effects of platelet transfusions and HLA in 66 cases of hematology malignance

恶性血液病患者游离Fas的检测及临床意义

The Serum Levels of Soluble Fas in Patients with Malignant Hematologic Diseases and its Clinical Implication

应用TCRVβ基因谱分析血液病与免疫性疾病的T细胞克隆性

T Cell Clonality in Hematological Disease and Autoimmune Disease Using Analysis of TCR V β Gene Repertoire

恶性血液病中的P（15）~（INK4B）基因甲基化

P_ ( 15 ) ~ ( INK4B ) gene methylation in malignant hematopoietic diseases

对部分病例进行动态观察，进一步证实上述结果。提示血清FA，B（12）含量与恶性血液病病情转归密切相关。

Serial determinations suggest that the folic acid and B_ ( 12 ) concentrations are closely correlated to the outcome of hematologic malignancies .

急性髓性白血病（AcutemyeloidLeukemia，AML）是一类起源于造血干细胞的、以大量遗传缺陷为特征的异质性恶性血液病。

Acute myeloid leukemia ( AML ) is a clonal and heterogeneous disease characterized by a myriad of genetic defects .

DNA甲基化能够抑制多种恶性血液病抑癌基因的表达，是恶性血液病发病的机制之一，并与预后密切相关。

The methylation of DNA can suppress the anti-oncogene in malignancy hematologic disease , which is one of the mechanisms in malignancy hematologic disease and related with prognosis intimate .

目的：探讨白介素2（IL2）对恶性血液病化疗患者免疫功能的影响。

Objective : To observe the effect of interleukin_2 on immunity function of patients with malignant hematologic disease under chemotherapy .

粒细胞集落刺激因子对恶性血液病化疗患者血清LDH和ALP及β2-MG的影响

Study on LDH , ALP ,β _2-MG in malignant hematology diseases treated with G-CSF

SNP芯片技术在恶性血液病中的应用

Application of SNP-Arrays in Hematological Malignancies & Review

PICC插管与锁骨下静脉插管在血液病患者中的应用比较

Comparison of PICC intubation and subclavian vein catheter applied in hematologic disease patients

目的探讨血液病患者血小板输注的治疗效果与人类组织相容性系统（HLA）之间的相关性。

Objective To explore the relationship between the therapeutic effects of platelet transfusion and human histocompatibility antigen system ( HLA ) .

恶性血液病p21~（WAF1）、CyclinE的表达及临床意义

The expression of p21 ~ ( WAF1 ) and Cyclin E and their clinical significance in malignant hematopoietic diseases

c-kit基因在恶性血液病研究中的进展

Advance of Research on c - kit Gene in Malignant Hematological Diseases

对126例血液病患者HCV和HBV感染及其病毒复制进行了研究。

The prevalences and replications of hepatitis C virus ( HCV ) and hepatitis B virus infections were investigated in patients with haematological diseases .

研究发现DNA甲基化是可逆的改变，逆转基因启动子区的甲基化能够使沉默基因重新表达，成为恶性血液病治疗的新靶点。

Studies found that DNA methylation is a reversible change , reverse gene promoter region methylation can make silence gene expression again , this is new targets for the treatment of hematologic malignancies .

目的探讨腹腔镜脾切除术（laparoscopicsplenectomyLS）治疗血液病的安全性、有效性及优越性。

Objective To explore the safety , efficacy , superiority of laparoscopic splenectomy ( LS ) in patients with hematologic diseases .

方法对1999年1月-2005年11月的恶性血液病患者，化疗后发生的46例医院ESBLs阳性细菌感染患者进行回顾性分析。

METHODS Forty six malignant hematopathy patients with nosocomial infection by ESBLs positive bacteria were studied retrospectively .